Have you been wondering whether VOXZOGO is right for your child? Join a webinar where you can hear firsthand about the steps one family took when deciding to start VOXZOGO, the support they received along the way, and how VOXZOGO fits in their lives now. You can also take the opportunity to ask a physician or a BioMarin representative any questions you may have.
This event is intended for families with a child aged 5 or older with achondroplasia.
VOXZOGO is an FDA-approved therapy for increasing linear growth in children with achondroplasia aged 5 years and up whose growth plates are still open.
VOXZOGO may cause serious side effects including a temporary decrease in blood pressure in some patients. To reduce the risk of a decrease in blood pressure and associated symptoms (dizziness, feeling tired, or nausea), patients should be well fed and hydrated in the hour before receiving VOXZOGO.
Pediatric Endocrinologist
Phoenix Children's Hospital
Phoenix, AZ
Parent of a child taking VOXZOGO
*Required fields.
This event is intended for families with a child aged 5 or older with achondroplasia.
What is the most important safety information about VOXZOGO?
What are the most common side effects of VOXZOGO?
How is VOXZOGO taken?
What should you tell the doctor before or during taking VOXZOGO?
You may report side effects to BioMarin at 1-866-906-6100. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Please see additional safety information in the full Prescribing Information and Patient Information.
What is VOXZOGO used for?
What is VOXZOGO used for?
What is the most important safety information about VOXZOGO?
What are the most common side effects of VOXZOGO?
How is VOXZOGO taken?
What should you tell the doctor before or during taking VOXZOGO?
You may report side effects to BioMarin at 1-866-906-6100. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Please see additional safety information in the full Prescribing Information and Patient Information.